2024
101. Hjortborg, M., Edin, S., Böckelman, C. et al. Systemic inflammatory response in colorectal cancer is associated with tumour mismatch repair and impaired survival. Sci Rep 14, 29738 (2024). https://doi.org/10.1038/s41598-024-80803-6
100. Nyirenda, J., Hardy, O.M., Silva Filho, J.D. et al. Spatially resolved single-cell atlas unveils a distinct cellular signature of fatal lung COVID-19 in a Malawian population. Nat Med (2024). https://doi.org/10.1038/s41591-024-03354-3
99. Bartel, A.; Aupperle-Lellbach, H.; Kehl, A.; Weidle, S.; Aeschlimann, L.; Klopfleisch, R.; Brot, S.d. Expression of Mutated BRAFV595E Kinase in Canine Carcinomas—An Immunohistochemical Study. Vet. Sci. 2024, 11, 584. https://doi.org/10.3390/vetsci11110584
98. Ria Winkelmann 1,* , Maja Weißgerber 1, Peter J. Wild 1,2, Julia Bein 1, Maximilian Fleischmann 3, Melanie Demes 1, Panagiotis Balermpas 3,4 , Andreas Loth 5, Katrin Bankov 1,6,† and Jens von der Grün 3,4,† Single Center Characterization of a Cohort of Salivary Gland Carcinomas Life 2024, 14(9), 1089; https://doi.org/10.3390/life14091089
97. Pu, X., Li, L., Xu, F. et al. HER2 amplification subtype intrahepatic cholangiocarcinoma exhibits high mutation burden and T cell exhaustion microenvironment. J Cancer Res Clin Oncol 150, 403 (2024). https://doi.org/10.1007/s00432-024-05894-0
96. Moser, Elisa; Ura, Ayako; Vogel, Loreen; Steiger, Katja; Mogler, Carolin; Evert, Matthias; Märkl, Bruno; Scheidhauer, Klemens; Martignoni, Marc; Friess, Helmut; von Werder, Alexander; Marinoni, Ilaria; Perren, Aurel; Klöppel, Günter; Kasajima, Atsuko (2024) ARX, PDX1, ISL1, and CDX2 Expression Distinguishes 5 Subgroups of Pancreatic Neuroendocrine Tumors With Correlations to Histology, Hormone Expression, and Outcome PMID39147030
DOI10.1016/j.modpat.2024.100595
95. Ogawa M, Tanaka A, Maekawa M, Namba K, Otani Y, Shia J, et al. (2024) Protein expression of the amino acid transporter SLC7A5 in tumor tissue is prognostic in early-stage colorectal cancer. PLoS ONE 19(5): e0298362.
https://doi.org/10.1371/journal.pone.0298362
94. De Wispelaere W, Annibali D, Tuyaerts S, et al. PI3K/mTOR inhibition induces tumour microenvironment remodelling and sensitises pS6high uterine leiomyosarcoma to PD-1 blockade. Clin Transl Med.
2024;14:e1655. https://doi.org/10.1002/ctm2.1655
93. Anna Ray Laurya, Shuyu Zhenga, Niina Ahoa, Robin Fallegger, Satu Hanninen, Julio Saez-Rodriguez, Jovan Tanevskic, Omar Youssefa, Jing Tanga, Olli Mikael Carpen. Opening the Black Box: Spatial Transcriptomics and the Relevance of Artificial Intelligence–Detected Prognostic Regions in High-Grade Serous Carcinoma May 02, 2024. DOI:https://doi.org/10.1016/j.modpat.2024.100508
92. Boyd, Sonja1; Mustamäki, Taru2; Sjöblom, Nelli1; Nordin, Arno3; Tenca, Andrea4; Jokelainen, Kalle4; Rantapero, Tommi5; Liuksiala, Thomas5; Lahtinen, Laura2; Kuopio, Teijo2; Kytölä, Soili6; Mäkisalo, Heikki3; Färkkilä, Martti4; Arola, Johanna1. NGS of brush cytology samples improves the detection of high-grade dysplasia and cholangiocarcinoma in patients with primary sclerosing cholangitis: A retrospective and prospective study. Hepatology Communications 8(4):e0415, April 2024. | DOI: 10.1097/HC9.0000000000000415
91. Angeloni, M., van Doeveren, T., Lindner, S., Volland, P., Schmelmer, J., Foersch, S., Matek, C., Stoehr, R., Geppert, C.I., Heers, H., Wach, S., Taubert, H., Sikic, D., Wullich, B., van Leenders, G.J., Zaburdaev, V., Eckstein, M., Hartmann, A., Boormans, J.L., Ferrazzi, F. and Bahlinger, V. (2024), A deep-learning workflow to predict upper tract urothelial carcinoma protein-based subtypes from H&E slides supporting the prioritization of patients for molecular testing. J Pathol Clin Res, 10: e12369. https://doi.org/10.1002/2056-4538.12369
90. Albert Grass, Atsuko Kasajima, Sebastian Foersch, Mark Kriegsmann, Alexander Brobeil, Maxime Schmitt, Daniel Wagner, Jelte Poppinga, Dominik Wiese, Elisabeth Maurer, Andreas Kirschbaum, Thomas Muley, Hauke Winter, Anja Rinke, Thomas M. Gress, Markus Kremer, Matthias Evert, Bruno Märkl, Alexander Quaas, Markus Eckstein, Markus Tschurtschenthaler, Günter Klöppel, Carsten Denkert, Detlef K. Bartsch, Moritz Jesinghaus. PITX2 as a Sensitive and Specific Marker of Midgut Neuroendocrine Tumors: Results from a Cohort of 1157 Primary Neuroendocrine Neoplasms. Mod Pathol 37 (2024) 100442 https://doi.org/10.1016/j.modpat.2024.100442.
89. Chang, YT., Prompsy, P., Kimeswenger, S. et al. MHC-I upregulation safeguards neoplastic T cells in the skin against NK cell-mediated eradication in mycosis fungoides. Nat Commun 15, 752 (2024). https://doi.org/10.1038/s41467-024-45083-8
88. Zhang, X., Li, L., Gao, F. et al. Fluorescent in situ hybridization has limitations in screening NRG1 gene rearrangements. Diagn Pathol 19, 1 (2024). https://doi.org/10.1186/s13000-023-01424-7
87. Qu, S.; Timmermans, A.M.; Heemskerk-Gerritsen, B.A.M.; Trapman-Jansen, A.M.A.C.; Broeren-Foekens, R.; Prager-van der Smissen, W.J.C.; El Hassnaoui, H.; van Tienhoven, T.; Bes-Stobbe, C.K.; Westenend, P.J.; et al. Expression and Localization of Ferritin-Heavy Chain Predicts Recurrence for Breast Cancer Patients with a BRCA1/2 Mutation. Cancers 2024, 16, 28. https://doi.org/10.3390/cancers16010028
2023
86. Edin, S., Gylling, B., Li, X., Stenberg A., Löfgren-Burström, A., Zingmark, C., van Guelpen, B., Ljuslinder, I., Ling, A., Palmqvist, R., (2023). Opposing roles by KRAS and BRAF mutation on immune cell infiltration in colorectal cancer – possible implications for immunotherapy. Br J Cancer (2023)
85. Ettinger, M., Burner, T., Sharma, A., Chang, Y., Lackner, A., Prompsy, P., M. Deli, I., Traxler, J., Wahl, G., Altrichter, S., Langer, R., Tsai, Y., R. Varkhande, S., Schoeftner, L., Iselin, C., Gratz, I., Kimeswenger, S., Guenova, E., & Hoetzenecker, W., (2023). Th17-associated cytokines IL-17 and IL-23 in inflamed skin of Darier disease patients as potential therapeutic targets. Nat Commun 14, 7470 (2023).
84. Toivanen, K., Kilpinen, S., Ojala, K., Merikoski, N., Salmikangas, S., Sampo, M., Bohling, T., Sihto, H., (2023) PDE3A Is a Highly Expressed Therapy Target in Myxoid Liposarcoma MDPI Vol. 15 (Issue 22), 10.3390/cancers15225308.
83. Salmikangas, M., Laaksonen, M., Edgren, H., Salgado, M., Suoranta, A., Mattila, P., Koljonen, V., Böhling, T., and Sihto, H. (2023). Neurocan expression associates with better survival and viral positivity in Merkel cell carcinoma. PLoS ONE 18, e0285524.
82. Bräutigam, K., Reinhard, S., Wartenberg, M., Forster, S., Greif, K., Granai, M., Bösmüller, H., Klingel, K., Schürch, C., M. (2023). Comprehensive analysis of SARS-CoV-2 receptor proteins in human respiratory tissues identifies alveolar macrophages as potential virus entry site. Histopathology 82, 846–859
81. Popiel-Kopaczyk, A., Grzegrzolka, J., Piotrowska, A., Olbromski, M., Smolarz, B., Romanowicz, H., Rusak, A., Mrozowska, M., Dziegiel, P., Podhorska-Okolow, M., et al. (2023). The Expression of Testin, Ki-67 and p16 in Cervical Cancer Diagnostics. CIMB 45, 490–500.
2022
80. Gatius, S.; Jove, M.; Megino-Luque, C.; Albertí-Valls, M.; Yeramian, A.; Bonifaci, N.; Piñol, M.; Santacana, M.; Pradas, I.; Llobet-Navas, D.; Pamplona, R.; Matías-Guiu, X.; Eritja, N. (2022). Metabolomic Analysis Points to Bioactive Lipid Species and Acireductone Dioxygenase 1 (ADI1) as Potential Therapeutic Targets in Poor Prognosis Endometrial Cancer. Cancers, 14 (12), 2842.
79. Flanagan, D. J.; Amirkhah, R.; Vincent, D. F.; Gundaz, N.; Gentaz, P.; Cammareri, P.; McCooey, A. J.; McCorry, A. M. B.; Fisher, N. C.; Davis, H. L.; Ridgway, R. A.; Lohuis, J.; Leach, J. D. G.; Jackstadt, R.; Gilroy, K.; Mariella, E.; Nixon, C.; Clark, W.; Hedley, A.; Markert, E. K.; Strathdee, D.; Bartholin, L.; Redmond, K. L.; Kerr, E. M.; Longley, D. B.; Ginty, F.; Cho, S.; Coleman, H. G.; Loughrey, M. B.; Bardelli, A.; Maughan, T. S.; Campbell, A. D.; Lawler, M.; Leedham, S. J.; Barry, S. T.; Inman, G. J.; van Rheenen, J.; Dunne, P. D.; Sansom, O. J. (2022). Epithelial TGFβ Engages Growth-Factor Signalling to Circumvent Apoptosis and Drive Intestinal Tumourigenesis with Aggressive Features. Nat Commun, 13 (1), 7551.
78 .Farkash, S.; Schwartz, N.; Edison, N.; Greenberg, S.; Peled, H. B.; Sindiany, W.; Krausz, J. (2022). Tissue Microarrey: A Potential Cost-Effective Approach for Mismatch Repair Testing in Colorectal Cancer. BMC Gastroenterol, 22 (1), 504.
77. Ugolini, F.; Szumera-Ciećkiewicz, A.; Baroni, G.; Nesi, G.; Mandalà, M.; Ferrone, S.; Massi, D. (2022). Differential HLA Class I Subunit (A, B, C Heavy Chain and Β2-Microglobulin) Expression Levels in Normal Tissues. Virchows Arch.
76. Benhamou, S., Fournier, E., Puppa, G., McKee, T., Ris, F., Rubbia, L., Viassolo, V., Zilli, T., Zlobec, I., Chappuis, P.O., et al. (2022). Cohort profile: population-b ased cohorts of patients with colorectal cancer and of their relatives in Geneva, Switzerland. Open access, 9.
75. Ferician, A.M., Ferician, O.C., Cumpanas, A.D., Berzava, P.L., Nesiu, A., Barmayoun, A., and Cimpean, A.M. (2022). Heterogeneity of Platelet Derived Growth Factor Pathway Gene Expression Profile Defines Three Distinct Subgroups of Renal Cell Carcinomas. Cancer Genomics Proteomics 19, 477–489.
74. Partynska, A., Gomulkiewicz, A., Piotrowska, A., Grzegrzolka, J., Rzechonek, A., Ratajczak-Wielgomas, K., Podhorska-Okolow, M., and Dziegiel, P. (2022). Expression of Zyxin in Non-Small Cell Lung Cancer—A Preliminary Study. Biomolecules 12, 827.
73. Ratajczak-Wielgomas, K., Kmiecik, A., and Dziegiel, P. (2022). Role of Periostin Expression in Non-Small Cell Lung Cancer: Periostin Silencing Inhibits the Migration and Invasion of Lung Cancer Cells via Regulation of MMP-2 Expression. IJMS 23, 1240.
72. Iaccarino, A., Acanfora, G., Pisapia, P., Malapelle, U., Bellevicine, C., Troncone, G., and Vigliar, E. (2022). Tissue Microarray from Cell Block Material (cbTMA)—An Additional Shot for Cytology in the Predictive Pathology Era: The PD-L1 Experience. JMP 3, 15–23.
71. Hladek, L., Bankov, K., von der Grün, J., Filmann, N., Demes, M., Vallo, S., Wild, P.J., and Winkelmann, R. (2022). Tumor-associated immune cell infiltrate density in penile squamous cell carcinomas. Virchows Arch.
70. Wozniak, S., Nowinska, K., Chabowski, M., and Dziegiel, P. (2022). Significance of Irisin (FNDC5) Expression in Colorectal Cancer. In Vivo 36, 180–188.
2021
69. Haslbauer, J.D., Stalder, A., Zinner, C., Bassetti, S., Mertz, K.D., Went, P., Matter, M., and Tzankov, A. (2021). Immunohistochemical and Transcriptional Analysis of SARS-CoV-2 Entry Factors and Renin-Angiotensin-Aldosterone System Components in Lethal COVID-19. Pathobiology, 1–12.
68. Carpenco, E., Fulga, V., David, V., Foca, E., Saptefrati, L., (2021) Mast cells in luminal vs non-luminal breast cancers E. Carpenco et al. Moldovan Medical Journal
67. Rubisz, P., Hirnle, L., and Kobierzycki, C. (2021) The Immunohistochemical Expression of MCM-3, -5, and -7 Proteins in the Uterine Fibroids Curr. Issues Mol. Biol.
66. Meriläinen, A-S., Sihto, H., and Koljonen, V. (2021) Merkel cell polyomavirus is a passenger virus in both poroma and porocarcinoma J Cutan Pathol.
65. Kaprio, H., Heuser, V. D., Orte, K., Tukiainen, M., Leivo, I., and Gardberg, M. (2021) Expression of Transcription Factor CREM in Human Tissues Journal of Histochemistry & Cytochemistry
64. Strohmeier, S., Brcic, I., Popper, H., Liegl-Atzwanger, B., Lindenmann, J., and Brcic, L. (2021) Applicability of pan-TRK immunohistochemistry for identification of NTRK fusions in lung carcinoma Scientific Reports
63. Viborg Lindskrog, S., Prip, F., […] and Dyrskjot, L. (2021) An integrated multi-omics analysis identifies prognostic molecular subtypes of non-muscle-invasive bladder cancer Nature Communications
62. Lee, C-J., Wozniak, A., Van Cann, T., Timmermans, I., Wellens, J., Vanleeuw, U., Briaire-de Bruijn, I. H., Britschgi, C., Bovée, J. V. M. G., Zlobec, I., Sciot, R. and Schöffski, P. (2021) Establishment of an Academic Tissue Microarray Platform as a Tool for Soft Tissue Sarcoma Research Sarcoma
61. Zadka, L., Chabowski, M., Grybowski, D., Piotrowska, A., and Dziegiel, P. (2021) Interplay of stromal tumor-infiltrating lymphocytes, normal colonic mucosa, cancer-associated fibroblasts, clinicopathological data and the immunoregulatory molecules of patients diagnosed with colorectal cancer Cancer Immunology, Immunotherapy
60. Weber, M., Homm, A., Müller, S., Frey, S., Amann, K., Ries, J., Geppert, C., Preidl, R., Möst, T., Kämmerer, P. W., Kesting, M. and Wehrhan, F. (2021) Zoledronate Causes a Systemic Shift of Macrophage Polarization towards M1 In Vivo International Journal of Medical Sciences
2020
59. Remoué, A., Conan-Charlet, V., Deiana, L., Tyulyandina, A., Marcorelles, P., Schick, U., and Uguen, A. (2020) Breast cancer tumor heterogeneity has only little impact on the estimation of Oncotype DX® recurrence score using Magee equations and Magee Decision Algorithm Human Pathology
58. Grzegrzolka, J., Olbromski, M., Gomulkiewicz, A., Piotrowska, A., Glatzel‑Plucinska, N., Ratajczak, K., Sputa‑Grzegrzolka, P., Rzechonek, A., Werynska, B., Podhorska‑Okolow, M., and Dziegiel, P. (2020) Role of tesmin expression in non‑small cell lung cancer Oncology Letters
57. Ciesielska, U., Piotrowska, A., Kobierzycki, C., Pastuszewski, W., Podhorska-Okolow, M., Dziegiel, P. and Nowinska, K. (2020) Comparison of TMA Technique and Routine Whole Slide Analysis in Evaluation of Proliferative Markers Expression in Laryngeal Squamous Cell Cancer in vivo
56. Gowkielewicz, M., Lipka, A., Majewska, M., Piotrowska, A., Szadurska-Noga, M., Nowakowski, J. J., Wiszpolska, M., Dziegiel, P., Wasniewski, T., Majewski, M. K. and Jozwik, M. (2020) Anti-Müllerian Hormone Type II Receptor Expression in Endometrial Cancer Tissue Cells
55. Carpenco, E. (2020) S100 protein in molecular subtypes of breast cancer Moldovan Medical Journal
54. Margan, M. M., Cimpean, A. M., Ceausu, A R., and Raica, M., (2020) Differential Expression of E-Cadherin and P-Cadherin in Breast Cancer Molecular Subtypes Anticancer Research
53. Lehmann, M., Marklund, M., Bolender, A-L., Bidhendi, E. E., Zetterström, P., Andersen, P. M., Brännström, T., Marklund, S. L., Gilthorpe, J. D. and Nordström, U. (2020) Aggregate-selective antibody attenuates seeded aggregation but not spontaneously evolving disease in SOD1 ALS model mice Acta Neuropathologica Communications
52. Deman, F., Punie, K., Laenen, A., Neven, P., Oldenburger, E., Smeets, A., Nevelsteen, I., Van Ongeval, C., Baten, A., Faes, T., Christiaens, M., Janssen, H., Weltens, C., Desmedt, C., Wildiers, H. and Floris, G. (2020) Assessment of stromal tumor infiltrating lymphocytes and immunohistochemical features in invasive micropapillary breast carcinoma with long-term outcomes Epidemiology
51. Luksza, M., Balachandran, V. P., Levin, A. J., Wolchok, J. D., Merghoub, T., Leach, S. D., Chan, T. A., Greenbaum, B. D., and Laessig, M. (2020) Neoantigens and uses thereof for treating cancer (United States Patent Application 20200232040) Free Patents Online
50. Contat, C., Ancey, P-B., Zangger, N., Sabatino, S., Pascual, J., Escrig, S., Jansen, L., Goepfert, C., Lanz, B. et al (2020) Combined deletion of Glut1 and Glut3 impairs lung adenocarcinoma growth eLife Sciences
49. Somri-Gannam, L., Meisel-Sharon, S., Hantisteanu, S., Groisman, G., Limonad, O., Hallak, M., and Bruchim, I. (2020) IGF1R Axis Inhibition Restores Dendritic Cell Antitumor Response in Ovarian Cancer Science Direct
48. Tanaka, A., Zhou, Y., Ogawa, M., Shia, J., Klimstra, D. S., Wang, J. Y., Roehrl, M. H. (2020) STAT1 as a potential prognosis marker for poor outcomes of early stage colorectal cancer with microsatellite instability PLOS One
47. Tian, C., Öhlund, D., Rickelt, S., Lidström, T., Huang, Y., Hao, L., Zhao, R. T., Franklin, O., Bhatia, S. N., Tuveson, D. A., Hynes, R. O. (2020) Cancer-cell derived matrisome proteins promote metastasis in pancreatic ductal adenocarcinoma Cancer Research
2019
46. Schoffski, P., Lee, C-J., Van Cann, T., Wellens, J., Zlobec, I., Bovée, J. V. M. G., Britschgi, C., Sciot, R., Wozniak. A. (2019)Establishment of a tissue microarray (TMA) platform as an efficient tool for soft tissue sarcoma (STS) research available for collaboration Journal of Global Oncology
45. Lasurinen, A,., Gramolelli, S., Hagström, J., Laitinen, A., Kokkola, A., Miki Y., Lehti, K., Yashiro, M., Ojala, P. M., Böckelman, C., Haglund C. (2019) High tissue MMP14 expression predicts worse survival in gastric cancer, particularly with a low PROX1 Wiley Cancer Medicine
44. Vesterinen T., Salmenkivi K., Mustonen H., Kuopio T., Lappi-Blanco E., Paavonen T., Vainio P., Knuuttila A., Carpén O., Haglund C., Arola J. (2019) Performance of Finnish biobanks in nationwide pulmonary carcinoid tumour research Virchows Archive
43. Böhm J., Muenzner J. K., Caliskan A., Ndreshkjana B., Erlenbach-Wünsch K., Merkel S., Croner R., Rau T. T., Geppert C. I., Hartmann A., Vial Roehe A., Schneider-Stock R. (2019) Loss of enhancer of zeste homologue 2 (EZH2) at tumor invasion front is correlated with higher aggressiveness in colorectal cancer cells Journal of Cancer Research and Clinical Oncology
42. Carpenco E., Ceaşu R. A., Cimpean A.M., Gaje P.N., Șaptefraţi L., Fulga V., David V., Raica M. (2019) Mast Cells as an Indicator and Prognostic Marker in Molecular Subtypes of Breast Cancer In Vivo
41. Hötzel K. J., Havnar C. A., Ngu H. V., Rost S., Liu S. D., Rangell L. K., Peale F. V. (2019) Synthetic Antigen Gels as Practical Controls for Standardized and Quantitative Immunohistochemistry Journal of Histochemistry & Cytochemistry
40. Aporowicz M., Czopnik P., Kubicka E., Piotrowska A., Dziegiel P., Bolanowski M. and Domoslawski P. (2019) Minichromosome Maintenance Proteins MCM-3, MCM-5, MCM-7, and Ki-67 as Proliferative Markers in Adrenocortical Tumors Anticancer Research
39. Pawelczyk K., Piotrowska A., Ciesielska U., Jablonska K., Glatzel-Plucinska N., Grzegrzolka J., Podhorska-Okolow M., Dziegiel P., and Nowinska K. (2019) Role of PD-L1 Expression in Non-Small Cell Lung Cancer and Their Prognostic Significance according to Clinicopathological Factors and Diagnostic Markers International Journal of Molecular Sciences
38. Kneppers J., Krijgsman O., Melis M., de Jong J., Peeper D. S., Bekers E., van der Poel H.G., Zwart W. Bergman A.M. (2019) Frequent clonal relations between metastases and non-index prostate cancer lesions
37. Haller F., Bieg M., Will R., Körner C., Weichenhan D., Bott A., Ishaque N., Lutsik P., Moskalev E.A., Mueller S.K., Bähr M., Woerner A., Kaiser B., Scherl C., Haderlein M., Kleinheinz K., Fietkau R., Iro H., Eils R., Hartmann A., Plass C., Wiemann S., Agaimy A. (2019) Enhancer hijacking activates oncogenic transcription factor NR4A3 in acinic cell carcinomas of the salivary glands Nature Communications volume 10, Article number: 368
2018
36. Birkman, E.-M., Mansuri, N., Kurki, S., Ålgars, A., Lintunen, M., Ristamäki, R., Sundström, J., and Carpén, O. (2018). Gastric cancer: immunohistochemical classification of molecular subtypes and their association with clinicopathological characteristics. Virchows Arch. 472, 369–382.
35. Conemans, E.B., Raicu-Ionita, G.M., Pieterman, C.R.C., Dreijerink, K.M.A., Dekkers, O.M., Hermus, A.R., Herder, W.W. de, Drent, M.L., Horst-Schrivers, A.N.A. van der, Havekes, B., et al. (2018). Expression of p27Kip1 and p18Ink4c in human multiple endocrine neoplasia type 1-related pancreatic neuroendocrine tumors. J Endocrinol Invest 41, 655–661.
34. David, S.N., Egloff, S.A.A., Goyal, R., Clark, P.E., Phillips, S., Gellert, L.L., Hameed, O., and Giannico, G.A. (2018). MAGI2 is an independent predictor of biochemical recurrence in prostate cancer. The Prostate 78, 616–622.
33. Depciuch, J., Stanek-Widera, A., Lange, D., Biskup-Frużyńska, M., Stanek-Tarkowska, J., Czarny, W., and Cebulski, J. (2018). Spectroscopic analysis of normal and neoplastic (WI-FTC) thyroid tissue. Spectrochim Acta A Mol Biomol Spectrosc 204, 18–24.
32. El Ansari, R., Craze, M.L., Miligy, I., Diez-Rodriguez, M., Nolan, C.C., Ellis, I.O., Rakha, E.A., and Green, A.R. (2018). The amino acid transporter SLC7A5 confers a poor prognosis in the highly proliferative breast cancer subtypes and is a key therapeutic target in luminal B tumours. Breast Cancer Research 20, 21.
31. Glatzel-Plucinska, N., Piotrowska, A., Grzegrzolka, J., Olbromski, M., Rzechonek, A., Dziegiel, P., and Podhorska-Okolow, M. (2018). SATB1 Level Correlates with Ki-67 Expression and Is a Positive Prognostic Factor in Non-small Cell Lung Carcinoma. Anticancer Res. 38, 723–736.
30. Guleria, P., Husain, N., Shukla, S., Kumar, S., Parshad, R., and Jain, D. (2018). PD-L1 immuno-expression assay in thymomas: Study of 84 cases and review of literature. Ann Diagn Pathol 34, 135–141.
29. Hadgu, E., Seifu, D., Tigneh, W., Bokretsion, Y., Bekele, A., Abebe, M., Sollie, T., Merajver, S.D., Karlsson, C., and Karlsson, M.G. (2018). Breast cancer in Ethiopia: evidence for geographic difference in the distribution of molecular subtypes in Africa. BMC Womens Health 18, 40.
28. Kobierzycki, C., Grzegrzolka, J., Glatzel-Plucinska, N., Piotrowska, A., Wojnar, A., Smolarz, B., Romanowicz, H., and Dziegiel, P. (2018). Expression of p16 and SATB1 in Invasive Ductal Breast Cancer – A Preliminary Study. In Vivo 32, 731–736.
27. Laedrach, C., Salhia, B., Cihoric, N., Zlobec,I., Tapia, C. (2018). Immunophenotypic profile of tumor buds in breast cancer. Pathol. Res. Pract. [Epub ahead of print]
26. Morin, E., Sjöberg, E., Tjomsland, V., Testini, C., Lindskog, C., Franklin, O., Sund, M., Öhlund, D., Kiflemariam, S., Sjöblom, T., et al. (2018) VEGF receptor-2/neuropilin1 trans-complex formation between endothelial and tumor cells is an independent predictor of pancreatic cancer survival. The Journal of Pathology 0.
25. Neyaz, A., Husain, N., Gupta, S., Kumari, S., Arora, A., Awasthi, N.P., Malhotra, K.P., and Misra, S. (2018). Investigation of targetable predictive and prognostic markers in gallbladder carcinoma. J Gastrointest Oncol 9, 111–125.
24. Neyaz, A., Husain, N., Kumari, S., Gupta, S., Shukla, S., Arshad, S., Anand, N., and Chaturvedi, A. (2018) Clinical relevance of PD-L1 expression in gallbladder cancer: a potential target for therapy. Histopathology 0.
23. Ooft, M.L., Ipenburg, J. van, Loo, R.J.M. van de, Jong, R. de, Moelans, C.B., Bree, R. de, Herdt, M.J. de, Koljenović, S., Jong, R.B. de, Hardillo, J., et al. (2018) Differences in cancer gene copy number alterations between Epstein-Barr virus-positive and Epstein-Barr virus-negative nasopharyngeal carcinoma. Head & Neck 0.
22. Pokataev, I., Kudaibergenova, A., Artemyeva, A., Popova, A., Rumyantsev, A., Podluzhny, D., Kudashkin, N., Fedyanin, M., Tryakin, A., and Tjulandin, S. (2018). Intratumoral Heterogeneity of SMAD4 Immunohistochemical Expression and Its Role in Prediction of Recurrence Pattern in Patients with Resectable Pancreatic Cancer. J Gastrointest Canc 1–7.
21. Suster, D., Pihan, G., Mackinnon, A.C., and Suster, S. (2018). Expression of PD-L1/PD-1 in lymphoepithelioma-like carcinoma of the thymus. Modern Pathology 1.Vesterinen,
20. T., Mononen, S., Salmenkivi, K., Mustonen, H., Ilonen, I., Knuuttila, A., Haglund, C., and Arola, J. (2018). Clinicopathological indicators of survival among patients with pulmonary carcinoid tumor. Acta Oncologica 57, 1109–1116.
19. Visser , N.C.M., Wurff, A.A.M. van der, Pijnenborg, J.M.A., Massuger, L.F.A.G., Bulten, J., and Nagtegaal, I.D. (2018). Tissue microarray is suitable for scientific biomarkers studies in endometrial cancer. Virchows Arch. 1–7.
18. Wartenberg, M., Cibin, S., Zlobec, I., Vassella, E., Eppenberger-Castori, S., Terracciano, L., Eichmann, M.D., Worni, M., Gloor, B., Perren, A., et al. (2018). Integrated Genomic and Immunophenotypic Classification of Pancreatic Cancer Reveals Three Distinct Subtypes with Prognostic/Predictive Significance. Clin Cancer Res.
17. Zadka, Ł., Kulus, M.J., Kurnol, K., Piotrowska, A., Glatzel-Plucińska, N., Jurek, T., Czuba, M., Nowak, A., Chabowski, M., Janczak, D., et al. (2018). The expression of IL10RA in colorectal cancer and its correlation with the proliferation index and the clinical stage of the disease. Cytokine 110, 116–125.
16. Graule, J., Uth, K., Fischer, E., Centeno, I., Galván, J.A., Eichmann, M., Rau, T.T., Langer, R., Dawson, H., Nitsche, U., et al. (2018). CDX2 in colorectal cancer is an independent prognostic factor and regulated by promoter methylation and histone deacetylation in tumors of the serrated pathway. Clin. Epigenetics 10, 120.
2017
15. Giovannetti, E., Zucali, P.A., Assaraf, Y.G., Funel, N., Gemelli, M., Stark, M., Thunnissen, E., Hou, Z., Muller, I.B., Struijs, E.A., et al. (2017). Role of proton-coupled folate transporter in pemetrexed-resistance of mesothelioma: clinical evidence and new pharmacological tools. Ann. Oncol.
14. Lin, F. (2017). Immunohistochemistry Quality Management Program Using Cultured Cell Lines for Tissue Microarray (TMA) Blocks.
13. Nolte, S., Zlobec, I., Lugli, A., Hohenberger, W., Croner, R., Merkel, S., Hartmann, A., Geppert, C.I., and Rau, T.T. (2017). Construction and analysis of tissue microarrays in the era of digital pathology: a pilot study targeting CDX1 and CDX2 in a colon cancer cohort of 612 patients. J. Pathol. Clin. Res. 3, 58–70.
12. Rau, K.-M., Su, Y.-L., Li, S.-H., Hsieh, M.-C., Wu, S.-C., Chou, F.-F., Chiu, T.-J., Chen, Y.-H., and Liu, C.-T. (2017). High expression of endoglin in primary breast cancer may predict response to neoadjuvant chemotherapy. Mol. Med. Rep. 16, 7185–7190.
2016
11. Green, W.J., Ball, G., Hulman, G., Johnson, C., Van Schalwyk, G., Ratan, H.L., Soria, D., Garibaldi, J.M., Parkinson, R., Hulman, J., et al. (2016). KI67 and DLX2 predict increased risk of metastasis formation in prostate cancer–a targeted molecular approach. Br. J. Cancer.
10. Koole, K., Clausen, M.J.A.M., Es, R.J.J., Kempen, P.M.W., Melchers, L.J., Koole, R., Langendijk, J.A., Diest, P.J., Roodenburg, J.L.N., Schuuring, E., et al. (2016). FGFR Family Members Protein Expression as Prognostic Markers in Oral Cavity and Oropharyngeal Squamous Cell Carcinoma. Mol. Diagn. Ther. 1–12.
9. Koole, K., Peeters, T., van Hengel, O.R.J., Brinkhuis, A., van Es, R.J.J., and Willems, S.M. (2016). RET protein is overexpressed in oral squamous cell carcinoma. Histopathology doi: 10.1111/his.13023.
8. Leenen, L. P. H., & Blokhuis, T. J. (2016). Neutrophils contribute to fracture healing by synthesizing fibronectin+ extracellular matrix rapidly after injury. Clinical Immunology, 164, 78–84.
2015
7. Aleskandarany, M., Caracappa, D., Nolan, C., C., Macmillan, D., R., Ellis, I., O., Rakha. E., A., and Green, A., E. (2015). DNA damage response markers are differentially expressed in BRCA-mutated breast cancers. Breast Cancer Research and Treatment. 10.1007/s10549-015-3306-6
6. Dale, Oliver T., Tamara Aleksic, Ketan A. Shah, Cheng Han, Hisham Mehanna, Davy C. M. Rapozo, Jon D. H. Shear. (2015). IGF-1R Expression Is Associated with HPV Negative Status and Adverse Survival in Head and Neck Squamous Cell Cancer. Carcinogenesis. bgv053. doi:10.1093/carcin/bgv053.
5. Lindskog, C., Linné, J., Fagerberg, L., Hallström, B.M., Sundberg, C.J., Lindholm, M., Huss, M., Kampf, C., Choi, H., Liem, D.A., et al. (2015). The human cardiac and skeletal muscle proteomes defined by transcriptomics and antibody-based profiling. BMC Genomics 16, 475.
4. Lacombe, A., Carafa, V., Schneider, S., Sticker-Jantscheff, M., Tornillo, L., and Eppenberger-Castori, S. (2015). Re-Punching Tissue Microarrays Is Possible: Why Can This Be Useful and How to Do It. Microarrays 4, 245–254.
3. Vassella, E., Galván, J.A., and Zlobec, I. (2015). Tissue Microarray Technology for Molecular Applications: Investigation of Cross-Contamination between Tissue Samples Obtained from the Same Punching Device. Microarrays 4, 188–195.
2014
2. Zlobec, I., Suter, G., Perren, A., and Lugli, A. (2014). A Next-generation Tissue Microarray (ngTMA) Protocol for Biomarker Studies. J. Vis. Exp. 91.
2013
1. Zlobec, I., Koelzer, V.H., Dawson, H., Perren, A., and Lugli, A. (2013). Next-generation tissue microarray (ngTMA) increases the quality of biomarker studies: an example using CD3, CD8, and CD45RO in the tumor microenvironment of six different solid tumor types. J. Transl. Med. 11, 104.;
